SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $839K invested in Scinai Immunotherapeutics in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$228K
2
+$94K
3
+$23K
4
UBS Group
UBS Group
Switzerland
+$10.8K

Top Sellers

1
-$51.9K
2
-$1.21K
3
-$1K
4
NC
NewSquare Capital
Pennsylvania
-$6
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$704K
2
$94K
3
$23K
4
$11.5K
5
$4.88K
6
$916
7
$346
8
$95
9
$43
10
$4
11
–
12
–